Project Syndicate: The End of Malaria?
Oluwatosin Omole, resident physician, and Babafemi Adenuga, associate professor, both in the Department of Community and Family Medicine at Howard University Hospital; and Joshua Adeoye, lecturer at Bayero University

“…The approval of Mosquirix opens a promising new phase in the fight against malaria. But serious challenges abound. To meet them, African countries must initiate, develop, and support homegrown research capacity and leaner models for delivering care. Research and investment in physical and social infrastructure must be a high priority as well. … At the very least, the world now has a new weapon in the fight to reduce the disease’s toll” (9/10).

The Conversation: How the world can cut malaria cases by 90% in the next 15 years
Collins Ouma, program head of health challenges and systems at the African Population and Health Research Centre at Maseno University

“…[O]ver the next 15 years, the number of malaria cases and deaths could be reduced by up to 90% if the agenda of the World Health Organisation and the Roll Back Malaria partnership is fully implemented. … A critical part of the new strategy and advocacy plan is that it anticipates the changes and increased resources that are needed to combat malaria. It also factors in the partnership’s needs to expand its engagement beyond its traditional partners. … There is a worldwide expectation that new structures will be put in place to engage key stakeholders, mobilize global action, and generate the required financial commitments to move towards the 2030 goal of cutting the malaria caseload by 90%” (9/10).